• Citer

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

par Bousser, MG;Amarenco, P;Chamorro, A;Fisher, Martin;Ford, Ian;Fox, K.;Hennerici, MG;Mattle, HP;Rothwell, PM;PERFORM Study Investigators, Massimo;Pandolfo,
Référence Cerebrovascular diseases, 27, 5, page (509-518)
Publication Publié, 2009

Article révisé par les pairs

• Détails
• Contenu

Titre:	Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Auteur:	Bousser, MG; Amarenco, P; Chamorro, A; Fisher, Martin; Ford, Ian; Fox, K.; Hennerici, MG; Mattle, HP; Rothwell, PM; PERFORM Study Investigators, Massimo; Pandolfo,
Informations sur la publication:	Cerebrovascular diseases, 27, 5, page (509-518)
Statut de publication:	Publié, 2009
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Aged, 80 and over
	Aspirin -- adverse effects
	Aspirin -- therapeutic use
	Cardiovascular Diseases -- etiology
	Cardiovascular Diseases -- prevention & control
	Dose-Response Relationship, Drug
	Double-Blind Method
	Endpoint Determination
	Female
	Humans
	International Cooperation
	Ischemic Attack, Transient -- complications
	Ischemic Attack, Transient -- drug therapy
	Male
	Middle Aged
	Naphthalenes -- adverse effects
	Naphthalenes -- therapeutic use
	Platelet Aggregation Inhibitors -- adverse effects
	Platelet Aggregation Inhibitors -- therapeutic use
	Propionic Acids -- adverse effects
	Propionic Acids -- therapeutic use
	Receptors, Thromboxane -- antagonists & inhibitors
	Stroke -- complications
	Stroke -- drug therapy
	Stroke -- etiology
	Stroke -- prevention & control
	Treatment Outcome
Note générale:	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1015-9770
	info:doi/10.1159/000212671
	info:pii/000212671
	info:pmid/19372653